Cytokinetics

CYTK US Health Care Biotechnology
S&P 400
$73.77
+0.20%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Cytokinetics belong to?
Cytokinetics operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of CYTK?
As of the latest available quote, CYTK traded at $73.77. This price is delayed and cached for about 15 minutes.
What is the market capitalisation of CYTK?
The market capitalisation of Cytokinetics is approximately $8.85B.
Is Cytokinetics profitable?
For its latest reported financial year, Cytokinetics recorded a negative net profit margin of about -891.60% (a net loss for the latest period).
Does CYTK pay a dividend?
Cytokinetics does not currently show a dividend yield in our data.
What is the return on equity (ROE) of CYTK?
Cytokinetics has a return on equity (ROE) of about 452.46%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of CYTK?
Over the past 52 weeks, CYTK has traded between a low of $47.22 and a high of $88.31.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.